> top > projects > sentences > docs > PubMed:32886791 > annotations
sentences Home  

PubMed:32886791 JSONTXT 32 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 0-88 Sentence denotes Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain.
T1 0-88 Sentence denotes Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain.
T2 89-255 Sentence denotes The novel coronavirus SARS-CoV-2, the infective agent causing COVID-19, is having a global impact both in terms of human disease as well as socially and economically.
T2 89-255 Sentence denotes The novel coronavirus SARS-CoV-2, the infective agent causing COVID-19, is having a global impact both in terms of human disease as well as socially and economically.
T3 256-464 Sentence denotes Its heavily glycosylated spike glycoprotein is fundamental for the infection process, via its receptor binding domains interaction with the glycoprotein angiotensin converting enzyme 2 on human cell surfaces.
T3 256-464 Sentence denotes Its heavily glycosylated spike glycoprotein is fundamental for the infection process, via its receptor binding domains interaction with the glycoprotein angiotensin converting enzyme 2 on human cell surfaces.
T4 465-650 Sentence denotes We therefore utilized an integrated glycomic and glycoproteomic analytical strategy to characterise both N- and O- glycan site specific glycosylation within the receptor binding domain.
T4 465-650 Sentence denotes We therefore utilized an integrated glycomic and glycoproteomic analytical strategy to characterise both N- and O- glycan site specific glycosylation within the receptor binding domain.
T5 651-812 Sentence denotes We demonstrate the presence of complex type N-glycans with unusual fucosylated LacdiNAc at both sites N331 and N343 and a single site of O-glycosylation on T323.
T5 651-812 Sentence denotes We demonstrate the presence of complex type N-glycans with unusual fucosylated LacdiNAc at both sites N331 and N343 and a single site of O-glycosylation on T323.